Xuetao Lu

Statistics

Publications

Citations

165

H-Index

Active since

2023

Affiliations

Mayo Clinic in Florida(Current)

The University of Texas MD Anderson Cancer Center

Massachusetts General Hospital

Xuetao Lu is an author at Mayo Clinic in Florida specializing in immune checkpoint inhibitors, non-small cell lung cancer therapy, and checkpoint inhibitor therapy.

ORCID

Publications per year

2023–2023

Publications

Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study

Maliazurina B. Saad, Lingzhi Hong, Muhammad Aminu et al. · The Lancet Digital Health · 2023 · 109 citations · Full text

Medicine, Cancer Biology, Oncology +17

Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer

Lingzhi Hong, Muhammad Aminu, Shenduo Li et al. · Nature Communications · 2023 · 56 citations · Full text

Medicine, Immunology, Oncology +17

1–2 of 2